Low hemoglobin at hemodialysis initiation: an international study of anemia management and mortality in the early dialysis period

Clinical Kidney Journal
Angelo KaraboyasBruce M Robinson

Abstract

Anemia at hemodialysis (HD) initiation is common. Correcting low hemoglobin (Hgb) before HD initiation may improve survival by avoiding potential harms of chronic anemia, high doses of erythropoiesis-stimulating agents (ESAs) and intravenous (IV) iron in the early HD period, and/or rapid Hgb rise. We included 4604 incident HD patients from 21 countries in the Dialysis Outcomes and Practice Patterns Study Phases 4-5 (2009-15). Because low Hgb at HD start may reflect comorbidity or ESA hyporesponse, we restricted our analysis to the 80% of patients who achieved Hgb ≥10 g/dL 91-120 days after HD start (Month 4). About 53% of these patients had Hgb <10 g/dL in Month 1 (<30 days after HD start); they were younger with a similar comorbidity profile (versus Hgb ≥10 g/dL). Month 1 Hgb was associated with first-year HD mortality (adjusted hazard ratio for 1 g/dL higher Hgb was 0.89; 95% confidence interval: 0.81-0.97), despite minimal differences in Month 4 Hgb. Patients with lower Hgb in Month 1 received higher doses of ESA, but not IV iron, over the first 3 months of HD. Results were consistent when excluding catheter users or adjusting for IV iron and ESA dose over the first 3 months. Even among patients with Hgb ≥10 g/dL 3 months la...Continue Reading

References

May 22, 2004·Journal of the American Society of Nephrology : JASN·Harold I FeldmanGerald Faich
Jul 22, 2005·Journal of the American Society of Nephrology : JASN·Kamyar Kalantar-ZadehDavid G Warnock
Nov 17, 2006·The New England Journal of Medicine·Tilman B DrüekeUNKNOWN CREATE Investigators
Nov 17, 2006·The New England Journal of Medicine·Ajay K SinghUNKNOWN CHOIR Investigators
Sep 25, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·H Andreas BockUNKNOWN Swiss EFIXNES trial investigators
Mar 6, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Brian D BradburyCathy W Critchlow
Nov 3, 2009·The New England Journal of Medicine·Marc A PfefferUNKNOWN TREAT Investigators
Jan 8, 2010·The New England Journal of Medicine·Ellis F UngerRobert Temple
Mar 6, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Ajay K Singh
Apr 30, 2010·Kidney International·Philip A McFarlaneDavid Mendelssohn
Jul 9, 2010·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Yoshiharu TsubakiharaTadao Akizawa
Apr 16, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesco LocatelliUNKNOWN ERA-EDTA ERBP Advisory Board
Jun 22, 2013·Journal of the American Society of Nephrology : JASN·M Alan BrookhartAbhijit V Kshirsagar
Jul 31, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Alan S KligerLynda Szczech
Oct 17, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Dana C MiskulinUNKNOWN Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network Patient Outcomes in End Stage Renal Disease Stu
Nov 5, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Navdeep TangriUNKNOWN DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators
Dec 30, 2014·Journal of the American Society of Nephrology : JASN·David M CharytanUNKNOWN Dialysis Advisory Group of the American Society of Nephrology
Apr 2, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ko-Lin KuoDer-Cherng Tarng
Oct 25, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Daniel ShepshelovichAnat Gafter-Gvili
Mar 18, 2017·Current Opinion in Nephrology and Hypertension·David CollisterNavdeep Tangri
Apr 25, 2017·Hemodialysis International·Lucia Del Vecchio, Francesco Locatelli
Feb 22, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Ingrid HougenNavdeep Tangri
Mar 7, 2018·Seminars in Dialysis·Hitesh H Shah, Steven Fishbane
Oct 27, 2018·The New England Journal of Medicine·Iain C MacdougallUNKNOWN PIVOTAL Investigators and Committees

❮ Previous
Next ❯

Software Mentioned

IVEware
TREAT
SAS

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Joanne H LauK Scott Brimble
© 2021 Meta ULC. All rights reserved